Home LiteratureArticle Details
PMID: 1976701 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 145 ·No. 8 ·1990-10-15 ·Pages 2669-76

Gendelman HE, Baca LM, Turpin J, Kalter DC, Hansen B, Orenstein JM, Dieffenbach CW, Friedman RM, Meltzer MS

Abstract

In a survey of 15 different virus isolates, no IFN-alpha or IFN-beta activity was detected in culture fluids of HIV-infected T cells or monocytes. Exogenous rIFN-alpha added to T lymphoblast or monocyte cultures induced restriction in replication of the amphotropic HIV that infect both cell types. With IFN-treated HIV-infected T cells, levels of reverse transcriptase (RT) activity in culture fluids were half those in control cultures, but the frequency of infected cells or the levels of p24 Ag released in culture fluids were unchanged. In contrast to the modest effect of IFN on HIV-infected T cells, IFN-induced antiviral activity in monocytes was quite dramatic. Monocytes treated with IFN at the time of virus challenge showed no evidence of HIV infection: no p24 Ag or RT activity, no viral mRNA, and no proviral DNA. In this system, IFN interrupts one or more early event(s) in the virus replication cycle before formation of proviral DNA. Monocyte cultures infected with HIV 7 days before IFN treatment showed a gradual decrease in levels of p24 Ag and RT activity to baseline by 3 wk. HIV-induced cytopathic changes were markedly reduced, and the frequency of productively infected cells was less than or equal to 1% of total cells. Virus particles released 24 h after IFN treatment were 100- to 1000-fold less infectious than equal numbers of control virions. But, monocytes treated with IFN 7 days after HIV infection were not free of the retroviral pathogen: levels of proviral DNA in the IFN-treated and control HIV-infected cells were indistinguishable. The presence of large quantities of proviral DNA in cells with little or no evidence for active transcription documents a situation approaching true microbiological latency.

MeSH Terms
CD4-Positive T-Lymphocytes/microbiology Cytopathogenic Effect, Viral DNA, Viral/analysis HIV/growth & development Humans In Vitro Techniques Interferon Type I/pharmacology Macrophages/microbiology Monocytes/microbiology Polymerase Chain Reaction RNA, Messenger/metabolism RNA, Viral/metabolism Time Factors Virus Replication/drug effects
Chemicals
DNA, Viral Interferon Type I RNA, Messenger RNA, Viral
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Gendelman H E
Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD 20852.
Baca L M
Turpin J
Kalter D C
Hansen B
Orenstein J M
Dieffenbach C W
Friedman R M
Meltzer M S
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1990-10-15
Pages
2669-76
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com